Swiss Pharmaceuticals & Biotech Insider-Bought Value Plays

Kuros Biosciences

Market Cap: CHF 846.0m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Idorsia

Market Cap: CHF 1.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.